O. Neill, L. A. Hardie, and D. G. , Metabolism of inflammation limited by AMPK and pseudo-starvation, Nature, vol.50, issue.7432, pp.346-55, 2013.
DOI : 10.1038/nature11862

S. Fogarty and D. G. Hardie, Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1804, issue.3, pp.581-91, 2010.
DOI : 10.1016/j.bbapap.2009.09.012

I. P. Salt and T. M. Palmer, Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation, Expert Opinion on Investigational Drugs, vol.12, issue.8, pp.1155-67, 2012.
DOI : 10.1677/JOE-09-0056

U. Muller-ladner, R. E. Gay, and S. Gay, Role of nuclear factor ??b in synovial inflammation, Current Rheumatology Reports, vol.31, issue.3, pp.201-208, 2002.
DOI : 10.1007/s11926-002-0066-1

D. Hammaker, S. Sweeney, and G. S. Firestein, Signal transduction networks in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.62, issue.90002, pp.86-95, 2003.
DOI : 10.1136/ard.62.suppl_2.ii86

G. S. Firestein, Evolving concepts of rheumatoid arthritis, Nature, vol.241, issue.6937, pp.356-61, 2003.
DOI : 10.1093/rheumatology/39.10.1060

R. E. Simmonds and B. M. Foxwell, Signalling, inflammation and arthritis: NF-??B and its relevance to arthritis and inflammation, Rheumatology, vol.47, issue.5, pp.584-90, 2008.
DOI : 10.1093/rheumatology/kem298

R. Prasad, S. Giri, N. Nath, I. Singh, and A. K. Singh, 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial???monocyte interaction, Journal of Neuroscience Research, vol.281, issue.3, pp.614-639, 2006.
DOI : 10.1002/jnr.20953

X. Zhao, J. W. Zmijewski, E. Lorne, G. Liu, Y. J. Park et al., Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury, AJP: Lung Cellular and Molecular Physiology, vol.295, issue.3, pp.497-504, 2008.
DOI : 10.1152/ajplung.90210.2008

A. Bai, M. Yong, A. G. Ma, Y. Ma, C. R. Weiss et al., Novel Anti-Inflammatory Action of 5-Aminoimidazole-4-carboxamide Ribonucleoside with Protective Effect in Dextran Sulfate Sodium-Induced Acute and Chronic Colitis, Journal of Pharmacology and Experimental Therapeutics, vol.333, issue.3, pp.717-742, 2010.
DOI : 10.1124/jpet.109.164954

B. Cool, B. Zinker, W. Chiou, L. Kifle, N. Cao et al., Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metabolism, vol.3, issue.6, pp.403-419, 2006.
DOI : 10.1016/j.cmet.2006.05.005

M. Guma, L. Ronacher, R. Liu-bryan, S. Takai, M. Karin et al., Caspase 1??????independent activation of interleukin-1???? in neutrophil-predominant inflammation, Arthritis & Rheumatism, vol.9, issue.12, pp.3642-50, 2009.
DOI : 10.1002/art.24959

C. A. Christianson, M. Corr, T. L. Yaksh, and C. I. Svensson, K/BxN Serum Transfer Arthritis as a Model of Inflammatory Joint Pain, Methods Mol Biol, vol.851, pp.249-60, 2012.
DOI : 10.1007/978-1-61779-561-9_19

P. J. Richards, A. S. Williams, R. M. Goodfellow, and B. D. Williams, Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis, Rheumatology, vol.38, issue.9, pp.818-843, 1999.
DOI : 10.1093/rheumatology/38.9.818

C. Ding, F. Cicuttini, J. Li, and G. Jones, Targeting IL-6 in the treatment of inflammatory and autoimmune diseases, Expert Opinion on Investigational Drugs, vol.58, issue.10, pp.1457-66, 2009.
DOI : 10.1038/nbt0908-957

M. Geyer and U. Muller-ladner, Actual status of antiinterleukin-1 therapies in rheumatic diseases, Current Opinion in Rheumatology, vol.22, issue.3, pp.246-51, 2010.
DOI : 10.1097/BOR.0b013e3283373fa0

G. Sethi, B. Sung, A. B. Kunnumakkara, and B. B. Aggarwal, Targeting TNF for Treatment of Cancer and Autoimmunity, Adv Exp Med Biol, vol.647, pp.37-51, 2009.
DOI : 10.1007/978-0-387-89520-8_3

S. Galic, M. D. Fullerton, J. D. Schertzer, S. Sikkema, K. Marcinko et al., Hematopoietic AMPK ??1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity, Journal of Clinical Investigation, vol.121, issue.12, pp.4903-4918, 2011.
DOI : 10.1172/JCI58577DS1

H. W. Jeong, K. C. Hsu, J. W. Lee, M. Ham, J. Y. Huh et al., Berberine suppresses proinflammatory responses through AMPK activation in macrophages, AJP: Endocrinology and Metabolism, vol.296, issue.4, pp.955-64, 2008.
DOI : 10.1152/ajpendo.90599.2008

D. Sag, D. Carling, R. D. Stout, and J. Suttles, Adenosine 5'-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype, The Journal of Immunology, vol.181, issue.12, pp.8633-8674, 2008.
DOI : 10.4049/jimmunol.181.12.8633

Y. D. Kim, Y. H. Kim, Y. M. Cho, D. K. Kim, S. W. Ahn et al., Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models, Diabetologia, vol.347, issue.5, pp.1482-94, 2012.
DOI : 10.1007/s00125-012-2494-4

N. L. Huang, S. H. Chiang, C. H. Hsueh, Y. J. Liang, Y. J. Chen et al., Metformin inhibits TNF-??-induced I??B kinase phosphorylation, I??B-?? degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation, International Journal of Cardiology, vol.134, issue.2, pp.169-75, 2009.
DOI : 10.1016/j.ijcard.2008.04.010

K. Y. Kang, Y. K. Kim, H. Yi, J. Kim, H. R. Jung et al., Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis, International Immunopharmacology, vol.16, issue.1, pp.85-92, 2013.
DOI : 10.1016/j.intimp.2013.03.020

B. Viollet, S. Horman, J. Leclerc, L. Lantier, M. Foretz et al., AMPK inhibition in health and disease, Critical Reviews in Biochemistry and Molecular Biology, vol.279, issue.2, pp.276-95, 2010.
DOI : 10.1152/ajplung.90210.2008
URL : https://hal.archives-ouvertes.fr/inserm-00489848

B. S. Jhun, Q. Jin, Y. T. Oh, S. S. Kim, Y. Kong et al., 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-?? production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages, Biochemical and Biophysical Research Communications, vol.318, issue.2, pp.372-80, 2004.
DOI : 10.1016/j.bbrc.2004.04.035

H. Koepsell, K. Lips, and C. Volk, Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications, Pharmaceutical Research, vol.61, issue.7, pp.1227-51, 2007.
DOI : 10.1007/s11095-007-9254-z

O. Goransson, A. Mcbride, S. A. Hawley, F. A. Ross, N. Shpiro et al., Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase, Journal of Biological Chemistry, vol.282, issue.45, pp.32549-60, 2007.
DOI : 10.1074/jbc.M706536200

E. E. Vincent, P. P. Coelho, J. Blagih, T. Griss, B. Viollet et al., Differential effects of AMPK agonists on cell growth and metabolism, Oncogene, vol.281, issue.28, 2014.
DOI : 10.1073/pnas.1312570111

J. T. Treebak, J. B. Birk, B. F. Hansen, G. S. Olsen, and J. F. Wojtaszewski, A-769662 activates AMPK ??1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle, AJP: Cell Physiology, vol.297, issue.4, pp.1041-52, 2009.
DOI : 10.1152/ajpcell.00051.2009

B. Benziane, M. Bjornholm, L. Lantier, B. Viollet, J. R. Zierath et al., AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase, AJP: Cell Physiology, vol.297, issue.6, pp.1554-66, 2009.
DOI : 10.1152/ajpcell.00010.2009

A. Salminen, J. M. Hyttinen, and K. Kaarniranta, AMP-activated protein kinase inhibits NF-??B signaling and inflammation: impact on healthspan and lifespan, Journal of Molecular Medicine, vol.9, issue.7, pp.667-76, 2011.
DOI : 10.1007/s00109-011-0748-0

Z. Yang, B. B. Kahn, H. Shi, and B. Z. Xue, Macrophage ??1 AMP-activated Protein Kinase (??1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1, Journal of Biological Chemistry, vol.285, issue.25, pp.19051-19060, 2010.
DOI : 10.1074/jbc.M110.123620

M. Yusof, M. Y. Emery, and P. , Targeting Interleukin-6 in Rheumatoid Arthritis, Drugs, vol.71, issue.10, pp.341-56, 2013.
DOI : 10.1007/s40265-013-0018-2

I. Ferraz-amaro, C. Gonzalez-juanatey, R. Lopez-mejias, L. Riancho-zarrabeitia, and M. A. Gonzalez-gay, Metabolic Syndrome in Rheumatoid Arthritis, Mediators of Inflammation, vol.14, issue.4, pp.710928-710938, 2013.
DOI : 10.1038/nrrheum.2012.158

T. Thalhamer, M. A. Mcgrath, and M. M. Harnett, MAPKs and their relevance to arthritis and inflammation, Rheumatology, vol.47, issue.4, pp.409-423, 2008.
DOI : 10.1093/rheumatology/kem297

C. J. Green, K. Macrae, S. Fogarty, D. G. Hardie, K. Sakamoto et al., Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor ??B signalling in rat skeletal muscle cells by AMP-activated protein kinase, Biochemical Journal, vol.290, issue.2, pp.463-74, 2011.
DOI : 10.1152/ajpendo.00293.2009

R. Y. Su, Y. Chao, T. Y. Chen, D. Y. Huang, and W. W. Lin, 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF??-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling, Molecular Cancer Therapeutics, vol.6, issue.5, pp.1562-71, 2007.
DOI : 10.1158/1535-7163.MCT-06-0800